Gill John
Altimmune, Inc. · Director
Gill John is listed in filings as Director at Altimmune, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including purchase activity. Recent filings connect the profile to Altimmune, Inc. (ALT). The current snapshot covers public activity from Sep 30, 2024 to May 1, 2026. Reported amounts are shown as $137.6K to $51.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $31k9.2k shares | BuyApr 6, 2026 | $3.41 | $2.87 |